Drawing for NANOREP

USPTO serial 79365657

NANOREP

Reviewed by CopyMark Law Group

Reg. 7452109Status 700Registered
Filing date
Status date
Registration date
Jul 23, 2024
Examiner
BROWN, TINA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NANOREP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey S. Standley

Jeffrey S. Standley Standley Law Group LLP6300 Riverside DriveDublin, OH 43017United States

Goods and services

ClassDescriptionStatusFirst use
009Laboratory pipettes, automatic laboratory pipettes, manual laboratory pipettes; electronic laboratory pipettes; repeating electronic laboratory pipettes; pipette tips; disposable positive-displacement syringes for laboratory use; capillary tubes for samples for laboratory use; laboratory pipette tip racks; disposable positive-displacement laboratory syringe racks; racks for capillary tubes for samples for laboratory use; storage boxes specially adapted for pipette tips for laboratory use; storage boxes specially adapted for disposable positive-displacement syringes for laboratory use; storage boxes specially adapted for capillary tubes for samples for laboratory use; containers specially designed for holding storage boxes for pipette tips for laboratory use, disposable positive-displacement syringes for laboratory use, or capillary tubes for samples for laboratory use; holders specially designed for holding laboratory pipette tip racks, racks for disposable positive-displacement syringes for laboratory use or for capillary tubes for samples for laboratory use; refill systems comprised of containers specially adapted for holding one or more laboratory pipette tip plates, plates with disposable positive-displacement syringes for laboratory use or with capillary tubes for samples for laboratory use, which may be removed from containers for refilling empty holders and storage boxes; laboratory pipette suspension device, namely, pipette racks for laboratory use, rail hang ups for laboratory pipettes, stands for laboratory pipettes; laboratory pipette racks and laboratory pipette holders, battery chargers for electronic laboratory pipettes; electric charging cables; battery chargers for laboratory pipette holders; sample plates for laboratory use; filters for laboratory pipettes, laboratory pipette tip adapters, membrane filters for laboratory pipettesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 1, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 14, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 14, 2025FIMPFINAL DISPOSITION PROCESSED—
Oct 23, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 23, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 23, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 8, 2024GPNXNOTIFICATION PROCESSED BY IB—
May 7, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 7, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 17, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 17, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 17, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 29, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 29, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Mar 29, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 29, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 29, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 24, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 24, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 24, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 7, 2023RFNTREFUSAL PROCESSED BY IB—
Oct 14, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 14, 2023RFRRREFUSAL PROCESSED BY MPU—
Sep 14, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 13, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 12, 2023DOCKASSIGNED TO EXAMINER—
Mar 31, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 27, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 23, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance